Nano-targeting treatment for prostate cancer
Metastatic or castrate-resistant prostate cancer can spread to the bone in certain patients. While several new treatments are available, they can have a difficult time...
NEWS INDEX
Mining for cancer clues
Credit: University of Delaware/ Wenbo Fan Doctors have many weapons in the fight against cancer, but choosing the right one can be a challenge. Soon...
Medicaid expansion under ACA linked to higher rate of smoking cessation
PITTSBURGH, Nov. 13, 2017 - When low-income adults were newly covered by Medicaid under the Affordable Care Act (ACA), they were more likely to quit...
The first effective therapy against glioblastoma by attacking telomeres
The Telomere and Telomerase Group at the Spanish National Cancer Research Centre (CNIO) has shown that it is possible to block the growth of human...
UC Davis, Leibniz Institute for Photonic Technologies partner in biophotoni
The University of California, Davis, and the Leibniz Institute for Photonic Technologies in Jena, Germany, have entered an agreement of cooperation to establish the Jena-Davis...
Genes that hold the clues to bladder cancer and its treatment
Scientists have discovered the 'genetic signatures' of the most common form of bladder cancer - and it could open up the possibility of better-targeted treatment,...
Cellular network identified that ‘short circuits’ the antitumor effect of immunotherapies
PHILADELPHIA -- (Nov. 13, 2017) -- Researchers from The Wistar Institute discovered a novel form of crosstalk among tumor cells and other cell types in...
Harder for T cells to fight cancer in absence of VEGF-A
Contrary to what was previously believed, the immune system's cancer-killing T cells are more effective in a tumour's anoxic environment when they have access to...
Engineering non-immune cells to kill cancer cells
Credit: ETH Zurich T-cells are one of the immune system's major weapons. They detect the body's cells infected with a virus and trigger their ablation,...
‘Mini liver tumors’ created in a dish for the first time
Scientists have created mini biological models of human primary liver cancers, known as organoids, in the lab for the first time. In a paper published...
Ludwig scientists share findings at 2017 Society for Neuro-oncology Annual Meeting
NOVEMBER 13, 2017, NEW YORK - Ludwig Cancer Research has released the scope of its participation at this year's Annual Meeting and Education Day of...
ESMO Precision Medicine Glossary published today
LUGANO, Switzerland, 13 November, 2017 - ESMO, the leading professional organisation for medical oncology, is pleased to announce the publication of the ESMO Precision Medicine...
PharmaMar presents positive results from a Phase II study of PM1183 in Ewing’s sarcoma
(Pharmamar) PharmaMar (MSE:PHM) has presented positive results from a Phase II study of lurbinectedin in Ewing´s sarcoma at the Connective Tissue Oncology Society´s (CTOS) International...
Epigenetic editing reveals surprising insights into early breast cancer development
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain reaction and become abnormal, according...
Cancer immunotherapy uses melanin against melanoma
Researchers have developed a melanin-enhanced cancer immunotherapy technique that can also serve as a vaccine, based on early experiments done in a mouse model. The...
